ANGIOTENSIN II RECEPTOR ANTAGONISTS
The CSM in the UK suggests that potassium should be measured in all patients
with risk factors (renal impairment, diabetes mellitus, pre-existing acidosis and those taking potassium-sparing drugs) before starting a low-molecular-weight heparin and monitored regularly thereafter (every 4 days has been suggested).
with risk factors (renal impairment, diabetes mellitus, pre-existing acidosis and those taking potassium-sparing drugs) before starting a low-molecular-weight heparin and monitored regularly thereafter (every 4 days has been suggested).